Shields, MD, L.B.E., Johnson, BS, T.A., Daniels, MS, M.W., Bell, MSN, RN, CPN, A., Siemens, PharmD, D.M., Jennings, MD, MBA, J.T., Hester, MD, MBA, S.T. and Honaker, MD, MBA, FAAP, J.T. 2021. Reduction in Schedule II opioid prescribing by primary care providers, orthopedic and general surgeons, and pain management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force. Journal of Opioid Management. 17, 2 (Mar. 2021), 155–167. DOI:https://doi.org/10.5055/jom.2021.0625.